• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有肝细胞癌的意大利丙型肝炎病毒患者因脑转移导致颅内出血。

Intracranial hemorrage due to brain metastases in an Italian HCV patient with hepatocellular carcinoma.

作者信息

Del Ben M, Caporale A, Feole K, Alessandri C, Angelico F

机构信息

Dept. of Experimental Medicine and Pathology, University of Rome La Sapienza, Rome, Italy.

出版信息

J Exp Clin Cancer Res. 2003 Dec;22(4):641-4.

PMID:15053309
Abstract

Brain metastases from hepatocarcinoma are exceptional and only a few cases have been reported in the literature, mainly from Far-Eastern countries. Clinical diagnosis in asymptomatic patients with preserved liver function is difficult and usually late. In some cases, cerebral metastasis is the initial manifestation of HCC and patients may develop intracerebral hemorrage and have a stroke-like presentation. We report on the first Italian case of cerebral metastases from multifocal hepatocellular carcinoma in an asymptomatic HbsAg negative patient with unknown HCV related chronic hepatitis and no evidence of liver cirrhosis. For many years he had a mild liver enzyme elevation and the presence of multiple misinterpreted hypoechogenic hepatic lesions. The hepatic tumor spread to the lungs and the brain and the patient developed two major episodes of intracranial hemorrage. He had two nodular lesions in the brain and alpha-fetoprotein levels were more than 10,000 ng/ml. He died from neurologic causes, without major signs of liver failure.

摘要

肝癌脑转移极为罕见,文献中仅报道过少数病例,主要来自远东国家。对于肝功能正常的无症状患者,临床诊断困难且通常较晚。在某些情况下,脑转移是肝癌的首发表现,患者可能会发生脑内出血,呈现类似中风的症状。我们报告了意大利首例多灶性肝细胞癌脑转移病例,患者无症状,乙肝表面抗原阴性,丙肝相关慢性肝炎情况不明,且无肝硬化证据。多年来,他的肝酶轻度升高,存在多个被误诊的低回声肝病灶。肝脏肿瘤扩散至肺部和脑部,患者发生了两次严重的颅内出血。他脑部有两个结节性病变,甲胎蛋白水平超过10,000 ng/ml。他死于神经原因,无严重肝功能衰竭迹象。

相似文献

1
Intracranial hemorrage due to brain metastases in an Italian HCV patient with hepatocellular carcinoma.一名患有肝细胞癌的意大利丙型肝炎病毒患者因脑转移导致颅内出血。
J Exp Clin Cancer Res. 2003 Dec;22(4):641-4.
2
Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.肝细胞癌肝移植的生存结果,比较丙型肝炎与其他肝硬化病因的影响。
Liver Transpl. 2007 Jun;13(6):807-13. doi: 10.1002/lt.21054.
3
Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.与肝炎病毒相关肝硬化患者肝细胞癌发生相关的临床和病理因素:一项长期随访研究
Clin Oncol (R Coll Radiol). 2007 Apr;19(3):197-203. doi: 10.1016/j.clon.2006.12.005. Epub 2007 Jan 18.
4
Clinical features of hepatocellular carcinoma with extrahepatic metastases.伴有肝外转移的肝细胞癌的临床特征。
J Gastroenterol Hepatol. 2005 Nov;20(11):1781-7. doi: 10.1111/j.1440-1746.2005.03919.x.
5
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.慢性肝炎、肝硬化和肝细胞癌患者的去γ-羧基凝血酶原、甲胎蛋白和甲胎蛋白-L3
J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.
6
[Fatal acute hepatic failure with hepatocarcinoma presentation in a patient with renal transplant with asymptomatic chronic B and C hepatitis].[肾移植患者合并无症状慢性乙型和丙型肝炎,以肝癌表现的致命性急性肝衰竭]
Medicina (B Aires). 2001;61(5 Pt 1):585-8.
7
High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.丙型肝炎病毒相关结节性肝细胞发育异常中的甲胎蛋白水平升高
Am J Gastroenterol. 1999 Aug;94(8):2296-7. doi: 10.1111/j.1572-0241.1999.01319.x.
8
Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.慢性丙型肝炎病毒感染相关的肝纤维化、肝硬化或肝细胞癌患者肝脏及血清中p53蛋白的表达
Clin Biochem. 2009 Apr;42(6):455-61. doi: 10.1016/j.clinbiochem.2008.11.004. Epub 2008 Nov 27.
9
The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.肿瘤坏死因子(TNF)-Fas配体及丙型肝炎病毒在肝细胞癌发生发展中的作用
J Clin Virol. 2005 Oct;34(2):140-6. doi: 10.1016/j.jcv.2005.02.012.
10
Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.肝脂肪变性与丙型肝炎相关肝硬化患者肝细胞癌发生频率增加有关。
Cancer. 2007 Jun 15;109(12):2490-6. doi: 10.1002/cncr.22701.

引用本文的文献

1
Cancer-associated stroke: Pathophysiology, detection and management (Review).癌症相关性卒中:病理生理学、检测与管理(综述)。
Int J Oncol. 2019 Mar;54(3):779-796. doi: 10.3892/ijo.2019.4669. Epub 2019 Jan 2.
2
Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study.初诊时脑转移的肝细胞癌列线图预测价值:一项基于人群的研究。
PLoS One. 2019 Jan 2;14(1):e0209293. doi: 10.1371/journal.pone.0209293. eCollection 2019.
3
The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
基于人群的分析:晚期肝癌患者不同转移模式的预后分析。
PLoS One. 2018 Aug 13;13(8):e0200909. doi: 10.1371/journal.pone.0200909. eCollection 2018.
4
Tumor markers for early diagnosis for brain metastasis of hepatocellular carcinoma: A case series and literature review for effective loco-regional treatment.肝细胞癌脑转移早期诊断的肿瘤标志物:有效局部区域治疗的病例系列及文献综述
Cancer Biol Ther. 2017 Feb;18(2):79-84. doi: 10.1080/15384047.2016.1276134. Epub 2017 Jan 3.
5
Gamma knife surgery for brain metastasis from hepatocellular carcinoma.伽玛刀治疗肝细胞癌脑转移瘤
PLoS One. 2014 Feb 7;9(2):e88317. doi: 10.1371/journal.pone.0088317. eCollection 2014.
6
Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors.肝癌脑转移:临床特征和预后因素。
BMC Cancer. 2012 Feb 1;12:49. doi: 10.1186/1471-2407-12-49.
7
Little response of cerebral metastasis from hepatocellular carcinoma to any treatments.肝细胞癌脑转移对任何治疗的反应都很小。
J Korean Neurosurg Soc. 2010 May;47(5):325-31. doi: 10.3340/jkns.2010.47.5.325. Epub 2010 May 31.
8
Brain metastases from hepatocellular carcinoma in US patients.美国患者肝细胞癌脑转移情况。
J Neurooncol. 2006 Jan;76(1):93-8. doi: 10.1007/s11060-005-4175-3.